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Abstract: 2-Bromopropane (2-BP) is used as an alternative to ozone-depleting cleaning 
solvents. Previously, we reported that 2-BP has cytotoxic effects on mouse blastocysts and is 
associated with defects in subsequent development. In the present work, we show that 2-BP 
induces apoptosis in the inner cell mass of mouse blastocysts, and inhibits cell proliferation. 
Both effects are suppressed by resveratrol, a grape-derived phytoalexin with known 
antioxidant and anti-inflammatory properties. 2-BP-treated blastocysts displayed lower 
levels of implantation (compared to controls) when plated on culture dishes in vitro, and a 
reduced ability to proceed to later stages of embryonic development. Pretreatment with 
resveratrol prevented 2-BP-induced disruption of embryonic development, both in vitro and 
in vivo. Further investigation of these processes revealed that 2-BP directly promotes ROS 
generation, loss of mitochondrial membrane potential (MMP), and activation of caspase-3, 
whereas resveratrol effectively blocks 2-BP-induced ROS production and the accompanying 
apoptotic biochemical changes. Our results collectively imply that 2-BP triggers the 
mitochondrion-dependent apoptotic pathway via ROS generation, and the antioxidant 
activity of resveratrol prevents 2-BP-induced toxicity. 
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1. Introduction 
2-Bromopropane (2-BP), a cleaning agent, is used as an alternative to ozone-depleting solvents.  
In 1995, 2-BP caused a series of reproductive and hematopoietic disorders in both female and male 
workers exposed to the material. The solvent was commonly used in an electronics factory located in 
South Korea [1,2]. Moreover, earlier reports found a high incidence of oligozoospermia in male workers 
after long-term exposure to 2-BP [1–3]. Several animal studies have further confirmed the potential of 
2-BP to injure the reproductive, hematopoietic, central nervous, and immune systems [4–11]. In 
cytotoxicity experiments, mouse embryos treated with 2-BP displayed micronuclear formation and a 
decrease in embryo cell number [12]. Moreover, 2-BP was recently identified as a potent DNA 
damaging agent [5,8]. These results collectively suggest that 2-BP induces various toxicities via DNA 
damage. A reproductive toxicity investigation further demonstrated that exposure to 2-BP induced 
testicular or ovarian dysfunction, causing injury to early types of spermatogenic cells or primordial 
follicles and oocytes of rats [4,6]. In experiments investigating the effects of 2-BP on pre- and postnatal 
development, exposure of pregnant or lactating female rats to 2-BP resulted in delivery rate decrease, 
peri- and postnatal death increase, loss of body weight development, and higher incidence of 
reproductive organ dysfunction [13]. It is true that, to date, no clinical or epidemiological study, or case 
report, has demonstrated a direct relationship between exposure of pregnant workers to 2-BP and 
reproductive problems. Specifically, there is no evidence to suggest that the solvent negatively affects 
embryonic development or infant growth. However, it is very important to explore the health risks 
associated with exposure of female workers, especially those who are pregnant, to 2-BP. Importantly, 
the solvent is very volatile and can permeate human skin. The major exposure route is via inhalation in 
the workplace or factory [1,2]. Moreover, a recent study by our group showed that 2-BP induces cellular 
apoptosis in both the ICM and TE of mouse blastocysts, leading to a decrease in implantation, a 
reduction in embryonic development, and a loss of embryo viability. Furthermore, our recent study 
results indicate that 2-BP induces developmental injury via induction of cell apoptosis processes in 
oocyte maturation and early-stage embryos [14]. These findings clearly suggest that short-term exposure 
to 2-BP is a risk factor for normal mouse embryonic development, and may inhibit oocyte maturation in 
infertile subjects.  
Resveratrol, a member of the phytoalexin family, found in grapes and other dietary plants, inhibits 
tumor initiation and progression [15–17]. Resveratrol exerts a wide range of pharmacological effects, 
including prevention of heart disorders, blocking of lipoprotein oxidation, and inhibition of platelet 
aggregation [18–20]. The anti-tumor properties of resveratrol have been attributed to an antioxidant 
activity and an ability to inhibit activation of cyclooxygenases [15,21,22], and may also be associated 
with a capacity to cause cell cycle arrest and apoptosis [23–27]. In earlier experiments by our group, 
pretreatment with resveratrol prevented ethanol-induced disruption of embryonic development both in 
vitro and in vivo [28]. Our results indicated that resveratrol reduces ethanol-induced injury (including 
apoptosis), inhibition of cell proliferation, and retardation of embryonic development, because of the 
antioxidant properties of the material [28]. Although several biological functions of resveratrol have  
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thus been established, the effects of the material on 2-BP-triggered injury, and the underlying 
mechanisms thereof, are currently unknown. 
To explore whether resveratrol prevents 2-BP-induced injury to embryos, we examined the effect of 
the compound on apoptosis, proliferation, and blastocyst development. Pretreatment with resveratrol 
effectively suppressed 2-BP-induced injury, including cell apoptosis, inhibition of cell proliferation, and 
retardation of embryonic development, both in vitro and in vivo. Further studies were conducted to 
elucidate the mechanisms underlying these effects. 
2. Results and Discussion 
We initially examined anti-cytotoxicity of resveratrol in mouse embryos on 2-BP exposure. 
Blastocysts were treated with 2.5–10 μM 2-BP for 24 h, and the level of apoptosis analyzed. 2-BP 
promoted apoptosis in mouse blastocysts in a dose-dependent manner. Quantitatively, apoptosis was 
7.5–11-fold more prevalent in 2-BP-treated blastocysts than in untreated controls (Figure 1A). However, 
apoptotic cells were not evident in blastocysts treated with 5–20 μM resveratrol (Figure 1A). We further 
examined the effects of resveratrol on 2-BP-promoted cell death in mouse blastocysts. 2-BP-induced 
apoptosis was prevented by pretreatment with 10–20 μM resveratrol (Figure 1B). Differential staining 
followed by cell counting was used to examine cell proliferation within blastocysts to explore the 
protective effects of resveratrol on cells treated with 2-BP (5 μM) for 24 h. ICM and TE cell numbers 
were significantly lower in blastocysts treated with 5 μM 2-BP, compared to cell numbers in controls 
(Figure 2A). Staining revealed significantly higher numbers of Annexin V-positive/PI-negative 
(apoptotic) cells in the ICM and TE of treated blastocysts, compared to controls (Figure 2B). These 
results show that 2-BP induces a significant level of apoptosis in the ICM and TE, of mouse blastocysts. 
Importantly, 2-BP-induced reduction in cell proliferation and apoptosis in blastocysts was effectively 
prevented by pretreatment with 10–20 μM resveratrol (Figures 2A and 2B). These findings collectively 
indicate that 2-BP causes embryonic apoptosis and reduced cell proliferation in vitro, both of which are 
effectively prevented by resveratrol. 
We further analyzed the effects of resveratrol and 2-BP on embryonic development in vitro. 
Approximately 86% of cultured morulae developed into blastocysts (Figure 3A). A similar proportion of 
morular development was observed in the resveratrol-treated group (data not shown). Development of 
blastocysts from morulae was reduced by 48.5% in the 5 μM 2-BP-treated group, but this impairment 
was significantly inhibited by pretreatment with 10–20 μM resveratrol (Figure 3A). We further analyzed 
the protective effect of resveratrol on outgrowth of embryos treated with 5 μM 2-BP in vitro. In the 
control group, most blastocysts attached to and expanded on fibronectin-coated dishes, whereas fewer 
blastocysts displayed such behavior after treatment with 5 μM 2-BP (i.e., most blastocysts either only 
attached, or only developed to the ICM+ stage) (Figure 3B). Furthermore, pretreatment with resveratrol 
prevented 2-BP-induced inhibition of attachment and outgrowth (Figure 3B). Additionally, we observed 
a significantly lower extent of outgrowth from 5 μM 2-BP-treated blastocysts that reached the ICM+++ 
stage (thus with a compact structured ICM) than from control blastocysts; this inhibition was prevented 
by pretreatment with resveratrol (Figure 3B). 
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Figure 2. Effect of resveratrol on cell viability in 2-BP-treated blastocysts. Blastocysts were 
pre-incubated with 5–20 μM RSVL for 1 h, followed by treatment without or with 5 μM 
2-BP for a further 24 h. (A) The total number of cells per blastocyst and cell numbers in the 
inner cell mass (ICM) and trophectoderm (TE) were counted; (B) The percentages of 
Annexin V-positive/PI-negative cells in the blastocysts of each group were examined. Data 
are based on at least 250 blastocyst samples from each group. *
 P < 0.05 and *** P < 0.001 
versus the control group; 
# P < 0.05 and 
### P < 0.001 vs. the 5 μM 2-BP-treated group. 
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embryos that failed to develop normally, resulting in embryo resorption in uterus, was significantly 
higher in the 2-BP-treated group (127 of 197 implanted embryos; 64.5%) than in controls (93 of 244 
implanted embryos; 38.1%) (Figure 4A). However, pretreatment with 10–20 μM resveratrol 
significantly suppressed 2-BP-induced disruption of embryonic development in the embryo transfer 
assay model (Figure 4A). No difference in placental weight was observed between the 5 μM 
2-BP-treated and control groups (Figure 4B), although average fetal weight was lower in the 
2-BP-treated group than in controls (479 ± 55 mg vs. 619 ± 71 mg, respectively). Consistent with our 
recent findings, 35–40% of fetuses weighed over 600 mg, and the average weight of total surviving 
fetuses was ~600 ± 12 mg, in the untreated control group at day 18 of pregnancy [29–33]. Fetal weight is 
an important indicator of developmental status. Accordingly, we used average fetal weight as a key 
marker of the effect of 2-BP on blastocyst development. In our experiments, only 20% of fetuses in the  
5 μM 2-BP-treated group weighed over 600 mg, whereas 40.8% of control fetuses exceeded this 
threshold (Figure 4C). Importantly, 39% of fetuses weighed over 600 mg in the group treated with both 
20 μM resveratrol and 5 μM 2-BP (Figure 4C). 
Figure 4. Effect of resveratrol on in vivo implantation, resorption, fetal survival and   
fetal weight in 2-BP-treated blastocysts. (A) Mouse morulae were preincubated with RSVL 
(5–20 μM) for 1 h, followed by treatment with 5 μM 2-BP for another 24 h. Implantations, 
resorptions and surviving fetuses were analyzed, as described in Materials and Methods. The 
percentage of implantations represents the number of implantations per number of 
transferred embryos ×100. The percentage of resorptions or surviving fetuses denotes the 
number of resorptions or surviving fetuses per number of implantations ×100; (B) The 
placental weights of 40 recipient mice were measured; (C) The weight distribution of 
surviving fetuses on day 18 post-coitus. Surviving fetuses were obtained by embryo transfer 
of control, RSVL and 2-BP-pretreated blastocysts, as described in the Materials and 
Methods (320 total blastocysts across 40 recipients). * P < 0.05 and *** P < 0.001 versus the 
control group; 
### P < 0.001 vs. 5 μM 2-BP-treated group. 
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Figure 4. Cont. 
 
 
Next, we examined the effects of resveratrol on 2-BP-induced disruption of blastocyst development 
in an animal model. Female mice were fed a standard diet and the drinking water contained either or both 
of resveratrol (20 μM) and 2-BP (20 μM). 2-BP consumption induced significant apoptosis and 
decreased the level of cell proliferation in mouse blastocysts (Figure 5A,B). In addition, 2-BP inhibited 
embryonic development to the blastocyst stage, resulting in frequent termination at the 2–16 cell or 
morula stage, or embryo degradation (Figure 5C). Dietary resveratrol effectively reduced these effects of 
2-BP (Figure 5A–C). Fetal weight was lower in the 2-BP-treated group than in controls, but was similar 
to that of control animals in the group receiving both resveratrol and 2-BP. Compared to the control 
group, the 2-BP-pretreated group contained fewer fetuses weighing over 600 mg (15%), whereas 29.1% 
of fetuses weighed over 600 mg in the group treated with resveratrol and 2-BP (Figure 5D). 
In light of recent findings, we conclude that ROS effectively induce apoptosis [33–35]. Moreover, a 
recent study pointed out that 2-BP impaired cellular antioxidation capacity and increased lipid 
peroxidation, which is inhibited by antioxidants such as melatonin [8,36]. In the present study, we used a 
fluorescent dye, DCF-DA, to measure ROS content in resveratrol- and 2-BP-treated mouse blastocyst 
cells. As shown in Figure 6A, 5  μM 2-BP induced an increase in fluorescence intensity in mouse 
blastocysts, compared with untreated control cells, and pretreatment with 20 μM resveratrol effectively 
blocked ROS generation (Figure 6A). To explore the effects of resveratrol on mitochondrial membrane 
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potential (MMP) changes in 2-BP-treated mouse blastocyst cells, we showed that pre-treatment with  
20 μM resveratrol blocked suppression of DiOC6 (3) uptake into the mitochondria of mouse blastocyst 
cells, indicative of resveratrol-mediated protection against significant MMP loss in blastocysts   
(Figure 6B). In addition, 5 μM 2-BP significantly stimulated caspase-3 activation, an important indicator 
of apoptosis, and this was inhibited by pre-treatment with resveratrol (Figure 6C). Based on these data, 
we suggest that 2-BP triggers ROS generation, in turn activating mitochondrion-dependent apoptotic 
processes, in mouse blastocyst cells. Resveratrol abolishes 2-BP-induced apoptosis and injury to 
blastocysts, because the material scavenges ROS. 
Figure 5. Effects of dietary resveratrol and 2-BP consumption on apoptosis and blastocyst 
development in an animal model. For the duration of the experiment, randomly selected 
female mice were fed a standard diet and drinking water supplemented with or without 
RSVL (20 μM) or/and 2-BP (20 μM). After 24 h, female mice were mated overnight with a 
single fertile male of the same strain and drinking water continuously supplemented with 
2-BP (20 μM) for 4 days. Blastocysts were obtained by flushing the uterine horn on day 4 
after mating. (A) Apoptosis of mouse blastocysts was examined by TUNEL staining 
followed by light microscopy, and the mean number of apoptotic (TUNEL-positive) cells per 
blastocyst calculated; (B) The total numbers of cells per blastocyst were counted; 
(C) Developmental stages were compared in embryos obtained from the mouse uterine 
horns on day 4. Data are presented as the percentage of total embryo obtained; (D) The 
weight distribution of surviving fetuses on day 18 post-coitus was measured. * P < 0.05,  
** P < 0.01 and 
*** P < 0.001 vs. the untreated control group; 
# P < 0.05, 
## P < 0.01 and  
### P < 0.001 vs. the 2-BP-treated group. 
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Embryonic development is a complex process during which chemical injury can lead to 
developmental problems or embryonic malformation. 2-BP has been shown to induce apoptosis, to 
impair oocyte maturation and fertilization, to affect blastocyst development from the morula, and to 
promote early-stage death of mouse blastocysts [14,37]. Thus, it is important to block the teratogenic 
effects of 2-BP in female workers exposed to the material. Here, we show, for the first time, that 
resveratrol significantly inhibits 2-BP-induced cell apoptosis and reduction of cell proliferation   
(Figures 1 and 2). Moreover, changes in the levels of cell cycle regulators, including PCNA and Ki67, 
were determined using real-time PCR in 2-BP-treated blastocysts. Expression of both proliferation 
markers was downregulated after treatment with 5 μM 2-BP, which was effectively prevented by 
resveratrol (data not shown). Thus, our results indicate that 2-BP significantly inhibits the proliferation 
of mouse blastocysts, and this effect is blocked by resveratrol. In our preliminary HPLC study, the 
mice’s drinking water containing 20 μM 2-BP for 4 days had serum 2-BP levels of about 5.63 μM [37]. 
Our current experiments clearly confirm the injurious effects of 5-10 μM 2-BP. Specifically, 2-BP in this 
concentration range induces apoptosis, causes a decrease in cell proliferation, and disrupts embryonic 
development, both in vitro and in vivo (Figures 1–4). In addition, drinking water with 20 μM 2-BP had 
adverse effects on both pre- and post-implantation embryonic development in an animal model (Figure 5). 
Clearly, 2-BP was hazardous to embryonic development at doses reflecting the physiological 
concentrations that may be attained through female workers exposed to this material. Importantly, 
pretreatment of 2-BP-treated embryos with resveratrol in vitro, or consumption of drinking water 
containing resveratrol in vivo, effectively suppressed 2-BP-induced effects on embryonic development 
(Figures 3–5). 
TE arises from the trophoblast at the blastocyst stage, and develops into a sphere of epithelial cells 
surrounding the ICM and blastocoel. These cells contribute to the placenta, and are required for 
development of the mammalian conceptus [38], signifying that a reduction in TE cell lineage may 
reduce implantation and embryonic viability [39,40]. Interestingly, in our experiments, 2-BP induced 
apoptosis in the ICM and TE, and had deleterious effects on the rate of implantation in vivo  
(Figures 2 and 4). However, this implantation and development injury was significantly prevented by 
resveratrol (Figure 4). Previous studies have reported that TE contributes to implantation and placenta 
formation. Moreover, ~ 30% or greater reduction in cell number in the ICM is associated with high risk 
of fetal loss or developmental injury, even in cases where implantation rate and TE cell numbers are 
normal [41]. In addition, the ICM cell number is essential for proper implantation, and reduction in the 
ICM lineage may decrease embryonic viability [39,40]. Apoptosis is responsible for eliminating 
unwanted cells during normal embryonic development, but does not normally occur at the blastocyst 
stage [42,43]. Excessive apoptosis before or during the blastocyst stage may result in the deletion of 
important cell lineages, impacting embryonic development and potentially leading to miscarriage or 
embryonic malformation [44]. In view of our observation that 2-BP reduces cell number and increases 
apoptosis in the ICM and TE of mouse blastocysts, we further investigated the possibility that the 
compound causes mortality and/or developmental delay in postimplantation mouse embryos in vitro and 
in vivo (Figures 2 and 4) and examined the potential of resveratrol in preventing this injury. 
A recent study found that 2-BP induces DNA damage, impairs functional antioxidant cellular 
defenses, and enhances the lipid peroxidation process in primary cultures of rat Leydig cells [8]. In 
addition, studies also found that pretreatment with melatonin protected against 2-BP-induced sperm Int. J. Mol. Sci. 2011, 12          
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injuries such as morphology, biochemical and histopathological features and apoptosis through its ROS 
scavenging and anti-apoptotic effects [36]. Oxidative stress is now recognized as a stimulator of cell 
responses such as apoptosis. Not only can direct exposure of cells to oxidative stress induce apoptosis, 
but antioxidants also protect cells against apoptosis induced by various stimuli that do not exert direct 
oxidant effects [45,46]. Moreover, addition of various anti-oxidants to culture media to prevent 
oxidative stress-induced damage of embryos can improve embryo development [47,48]. Using embryo 
culture media supplemented with anti-oxidant precursors such as β-mercaptoethanol, cysteamine and 
vitamin E is beneficial for embryonic inner cell mass (ICM) development [49,50]. In this report, we 
showed that 2-BP-induced hazardous effects on embryonic development could be blocked by resveratrol 
in mouse blastocysts (Figures 3–5). Importantly, our study further found that 5 μM 2-BP directly induced 
ROS generation and through mitochondrion-dependent apoptotic pathway to trigger cell death in mouse 
blastocysts (Figure 6). These findings indicate that 2-BP can directly evoke ROS generation and 
apoptosis. Thus, identification of ROS scavengers in dietary foods will be important for prevention of 
2-BP-triggered inhibition of embryonic development. Previously, pretreatment with melatonin 
effectively prevented 2-BP-induced reproductive toxicity in rats through its antioxidant properties [36]. 
These results imply that 2-BP cause embryonic development injury through ROS and its hazardous 
effects can be prevented by antioxidants.  
The inhibition by resveratrol of the apoptotic biochemical changes triggered by various stimuli have 
been attributed to the antioxidant properties of the material [28,51–53]. Resveratrol exerts a powerful 
antioxidant effect against multiple forms of ROS (e.g., O2
− and H2O2) produced in macrophages 
stimulated with lipopolysaccharides or phorbol esters, which induce O2
- synthesis via the NADPH 
oxidase pathway [54]. In addition, the specific effects of resveratrol on ethanol-induced ROS generation, 
intracellular ATP levels, and apoptosis or necrosis in K562 cells, may be dose-dependent [52]. 
Furthermore, resveratrol prevents ethanol-induced impairment of embryonic development [28]. These 
previous findings, in conjunction with our current results, clearly indicate that resveratrol attenuates 
ethanol- or 2-BP-induced ROS generation and apoptosis in mouse embryos, supporting the hypothesis 
that the compound suppresses cell death via inhibition of ROS production. Importantly, pretreatment 
with resveratrol could not fully prevent impairment by 2-BP but only reduced the hazardous effects of 
2-BP on embryo development, possibly due to the following reasons: (1) the treatment dosage and 
time-period of resveratrol were not optimal and require further examination; (2) the hazardous effects of 
2-BP on embryo development may be exerted through not only ROS but also other injury mechanisms, 
which cannot be prevented by resveratrol. The underlying regulatory mechanisms thus need further 
investigation. 
3. Experimental Section 
3.1. Chemicals 
Pregnant mare serum gonadotropin (PMSG), bovine serum albumin (BSA), sodium pyruvate, 
resveratrol and 2-Bromopropane were purchased from Sigma (St. Louis, MO, USA). Human chorionic 
gonadotropin (hCG) was obtained from Serono (NV Organon Oss, the Netherlands). The TUNEL in situ 
cell death detection kit was purchased from Roche (Mannheim, Germany), and CMRL-1066 medium 
from Gibco Life Technologies (Grand Island, NY, USA). Int. J. Mol. Sci. 2011, 12          
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3.2. Collection of Mouse Morulae and Blastocysts 
ICR mice were acquired from the National Laboratory Animal Center (Taiwan, ROC). Our research 
was also approved by the Animal Research Ethics Board of Chung Yuan Christian University (Taiwan, 
ROC). All animals received humane care, as outlined in the Guidelines for Care and Use of 
Experimental Animals (Canadian Council on Animal Care, Ottawa, 1984). Mice were maintained on 
breeder chow (Harlan Teklad chow), with food and water available ad libitum. Animals were housed in 
standard 28 cm × 16 cm × 11 cm (height) polypropylene cages with wire-grid tops, and maintained 
under a 12 h day/12 h night regimen. Nulliparous females (6–8 weeks old) were superovulated via 
injection of 5 IU PMSG, followed by 5 IU hCG injection 48 h later, and mated overnight with a single 
fertile male of the same strain. The day of vaginal plug identification was defined as “day 0” of gestation. 
Plug-positive females were separated for experimentation. Morulae were obtained by flushing uterine 
tubes on the afternoon of gestation day 3, and blastocysts acquired by flushing the uterine horn on day 4. 
In both cases, the flushing solution consisted of CMRL-1066 culture medium containing 1 mM 
glutamine and 1 mM sodium pyruvate. The glucose concentration in this medium was 5 mM. Expanded 
blastocysts from different females were pooled and randomly selected for experiments.  
3.3. Resveratrol and 2-BP Treatments and TUNEL Assay 
Blastocysts were incubated in medium containing various concentrations of resveratrol (5, 10 or 20 μM) 
for 1 h, followed by treatment with 2-BP (2.5, 5 or 10 μM) for a further 24 h. For apoptosis detection, 
embryos were washed in 2-BP-free medium, fixed, permeabilized and subjected to TUNEL labeling 
using an in situ cell death detection kit (Roche Molecular Biochemicals, Mannheim, Germany), 
according to the manufacturer’s protocol. Photographic images were obtained under bright-field 
illumination using a fluorescence microscope. 
3.4. Measurement of Cell Proliferation 
Blastocysts were incubated in medium containing various concentrations of resveratrol (5, 10 or 20 μM) 
for 1 h, followed by treatment with 2-BP (2.5, 5 or 10 μM) for a further 24 h. Next, blastocysts were 
washed with 2-BP-free medium, and dual differential staining used to facilitate counting of cell numbers 
in the inner cell mass (ICM) and trophectoderm (TE) [39]. Blastocysts were incubated in 0.4% pronase 
in M2-BSA (M2 medium containing 0.1% bovine serum albumin) for removal of the zona pellucida. 
Denuded blastocysts were exposed to 1 mM trinitrobenzenesulphonic acid (TNBS) in BSA-free M2 
medium containing 0.1% polyvinylpyrrolidone (PVP) at 4 °C for 30 min, and washed with M2  
medium [55]. Further treatment of blastocysts with 30 μg/mL anti-dinitrophenol-BSA complex antibody 
in M2-BSA at 37 °C for 30 min was followed by incubation in M2 supplemented with 10% whole guinea 
pig serum as a source of complement, along with 20 μg/mL bisbenzimide and 10 μg/mL propidium 
iodide (PI), at 37 °C for 30 min. Immunolysed blastocysts were gently transferred to slides and protected 
from light before observation. Under UV light excitation, ICM cells (that take up bisbenzimide but 
exclude PI) appeared blue, whereas TE cells (that take up both fluorochromes) appeared orange-red. 
Since multinucleated cells are not common in preimplantation embryos [56], the number of nuclei 
represented an accurate measurement of cell number. Int. J. Mol. Sci. 2011, 12          
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3.5. Annexin V Staining 
Blastocysts were incubated in medium containing various concentrations of resveratrol (5, 10 or  
20 μM) for 1 h, and treated with 2-BP (2.5, 5 or 10 μM) for a further 24 h. For apoptotic staining, 
embryos were washed in 2-BP-free medium and stained using an Annexin V-FLUOS staining kit 
(Roche), according to the manufacturer's instructions. Briefly, blastocysts were incubated in M2-BSA for 
removal of the zona pellucida, washed with PBS plus 0.3% BSA, and incubated for 60 min with a 
mixture of 100 μL binding buffer, 1 μL fluorescein isothiocyanate (FITC)-conjugated Annexin V and  
1 μL PI. After incubation, embryos were washed and photographed under fluorescent illumination. 
Annexin V+/PI- stained cells were considered apoptotic, and Annexin V+/PI+ cells necrotic.  
3.6. Morphological Analysis of Embryonic Development 
Blastocysts were cultured according to a modification of the previously reported method [57]. Briefly, 
embryos were cultured in 4-well multidishes at 37 °C. For group culture, four embryos were cultured per 
well. The basic medium consisted of CMRL-1066 supplemented with 1 mM glutamine and 1 mM 
sodium pyruvate plus 50 IU/mL penicillin and 50 mg/mL streptomycin (hereafter called culture 
medium). For treatments, the embryos were cultured with the presence or absence of resveratrol (5, 10 or 
20 μM) for 1 h, and treated with various concentrations of 2-BP (2.5, 5 or 10 μM). After 24 h, treated 
blastocysts were individually transferred to fibronectin-coated culture wells and grown for 72 h in 
CMRL-1066 medium supplemented with 20% fetal bovine serum (CMRL-FBS) [58]. Thereafter, the 
embryos were cultured for 3 days in culture medium supplemented with 20% fetal calf serum, and for  
4 days in culture medium supplemented with 20% heated-inactivated human placental cord serum, for a 
total culture time of 8 days from the onset of treatment. Embryos were inspected daily under a 
phase-contrast dissecting microscope, and developmental stages were classified according to established 
methods [58,59]. Under these culture conditions, each hatched blastocyst attached to the fibronectin and 
grew to form a cluster of ICM cells over the trophoblastic layer via in a process called TE outgrowth. 
After a total incubation period of 96 h, morphological scores for outgrowth were estimated. Growing 
embryos were classified as either ‘attached’ or ‘outgrowth’, with the latter defined by the presence of a 
cluster of ICM cells over the trophoblastic layer. As described previously [28,60], ICM clusters were 
scored according to shape, ranging from compact and rounded ICM (+++) to a few scattered cells (+) 
over the trophoblastic layer. 
3.7. Blastocyst Development Following Embryo Transfer 
To examine the ability of expanded blastocysts to implant and develop in vivo, generated embryos 
were transferred to recipient mice. ICR females (white skin color) were mated with vasectomized males 
(C57BL/6J; black skin color; National Laboratory Animal Center, Taiwan, ROC) to produce 
pseudopregnant dams as recipients for embryo transfer. To ensure that all fetuses in pseudopregnant 
mice came from embryo transfer (white color) and not fertilization by C57BL/6J (black color), we 
examined the skin color of fetuses at day 18 post-coitus. For assessment of the effects of resveratrol and 
2-BP on postimplantation growth in vivo, blastocysts were exposed to resveratrol (5, 10 or 20 μM) for 
1 h, and treated with 2-BP (2.5, 5 10 μM) for 24 h, following which 8 embryos were transferred in Int. J. Mol. Sci. 2011, 12          
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parallel to the paired uterine horns of day 4 pseudopregnant mice. Surrogate mice were killed on day 18 
post-coitus, and the frequency of implantation calculated as the number of implantation sites per number 
of embryos transferred. The incidence rates of resorbed and surviving fetuses were calculated as the 
number of resorbed or surviving fetuses, respectively, per number of implantations. Weights of surviving 
fetuses and placenta were measured immediately after dissection. 
3.8. ROS Assay 
ROS were measured in arbitrary units using the DCF-DA fluorescent dyes. Briefly, Embryos were 
incubated in 20 μM DCF-DA for 1 h at 37 °C, and relative ROS units were determined with a 
fluorescence ELISA reader (excitation at 485 nm, emission at 530 nm). An aliquot of each cell 
suspension was lysed, and the protein concentrations were determined using a BCA protein assay kit 
(Pierce, Rockford, IL). The results are expressed as arbitrary absorbance units/mg protein. 
3.9. Detection of the Mitochondrial Membrane Potential (MMP) and Caspase-3 Activity 
Embryos were exposed to the fluorescent dyes DiOC6 (3) for 15 min, and fluorescence was measured 
with a plate spectrofluorometer (excitation at 485 nm and emission at 535 nm). Caspase-3 activity was 
measured using the fluorogenic substrate Z-DEVD-AFC. Activation of caspase-3 was inhibited by 
Acetyl Asp-Glu-Val-Asp aldehyde (Ac-DEVD-cho) (Calbiochem, La Jolla, CA). 
3.10. Statistical Analyses 
Data were analyzed using one-way ANOVA, and t-tests presented as mean values ± SEM, with 
significance at P < 0.05. 
4. Conclusions 
In conclusion, resveratrol, a natural food compound, prevents 2-BP-caused embryonic development 
injury via blockage of ROS generation, confirming the potential of the material for development as a 
health food supplement to prevent 2-BP-induced teratogenic effects. 
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